22 reports

  • SEGMENTATION OF GLOBAL CONJUNCTIVITIS MEDICATION MARKET BASED ON CONDITION TYPE 2014
  • GLOBAL BACTERIAL CONJUNCTIVITIS MEDICATION MARKET 2014-2019 ($ BILLIONS)

Vernal, or seasonal conjunctivitis, is often associated with eczema or asthma.

  • Anti-Infective
  • Ophthalmic Solution
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc

In May 2017, the Danish Asthma and Allergy association launched a national campaign called " Snot or Not".

  • Ophthalmic Solution
  • OTC
  • Denmark
  • Demand
  • Orkla Group

Asthma & Allergy Association) Economic & Legal Framework for Non- Prescription Medicines (AESGP) Ehälsomyndigheten FASS Läkemedelsverket Förvaltningsrätten (The Administrative Court) Läkemedelsverket (Medical Products Agency - Sweden) LIF Medical Products Agency SCB (Statistics Swed

  • Ophthalmic Solution
  • Sweden
  • Forecast
  • GlaxoSmithKline plc
  • Orkla Group

CURRENT ALLERGY AND ASTHMA REPORTS; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Herantis Pharma Plc
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Chapter 5: Ophthalmic Anti-Allergy / Inflammatory / Infective Market 2014 - 2024

ALLERGIC CONJUNCTIVITIS IS COMMON IN PEOPLE WHO HAVE OTHER ALLERGIC DISEASE SUCH AS HAY FEVER, ASTHMA AND ECZEMA.

  • Ophthalmic Solution
  • Alcon, Inc.
  • Allergan plc
  • Merck & Co., Inc.
  • Novartis AG
  • Patent
  • Ophthalmic Solution
  • World
  • Forecast
  • Market Size
  • Galderma S.A.
  • Clinical Trial profile. 43 Trial Title
  • Clinical Trial Profile Snapshots
  • Healthcare
  • Ophthalmic Solution
  • OTC
  • World
  • Product Initiative
  • Clinical Trial profile. 3 Trial Title
  • Clinical Trial profile. 141 Trial Title
  • Allergy Drug
  • Ophthalmic Solution
  • World
  • Product Initiative
  • Circassia Pharmaceuticals plc
  • ALLERGIC CONJUNCTIVITIS - PIPELINE BY GRIFFIN DISCOVERIES BV, H2 2017
  • Allergic Conjunctivitis - Companies Involved in Therapeutics Development

The company offers pipeline formulations for atopic dermatitis, allergic conjunctivitis, allergic asthma, and allergic rhinitis.

  • Ophthalmic Solution
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Clinical Trial profile. 121 Trial Title
  • Clinical Trial profile. 299 Trial Title
  • Allergy Drug
  • Ophthalmic Solution
  • Therapy
  • World
  • Alcon, Inc.
  • Clinical Trial profile. 406
  • Clinical Trial profile. 493

Pteronyssinus in Patients with Asthma, Mild or Moderate Intensity, Hypersensitivity Domestic Dust Mites\ Clinical Trial, Multicenter, Randomized, Double-blind, Placebo Slit Extract Allergen D.

  • Allergy Drug
  • Clinical Trial
  • Ophthalmic Solution
  • World
  • Alcon, Inc.
  • Clinical Trial profile. 207 Trial Title
  • Clinical Trial profile. 195 Trial Title
  • Allergy Drug
  • Ophthalmic Solution
  • OTC
  • World
  • Product Initiative

Marinomed also develops MAM-##. ##, an allergy compound that provides an alternative to skin allergy, allergic asthma and allergic contact dermatitis.

  • Eye Disease
  • Ophthalmic Solution
  • United States
  • M&A
  • NicOx S.A.
  • Official Title
  • Clinical Trial profile. 161 Trial Title

Asthma, Grass Pollen Allergy (Immunoglobulin E (IgE), Immunoglobulin G## (IgG##)) Completed Phase II Interventional Avanz ALK-Abello A/ S ## Feb 2009 ## Aug 2009 ## ## ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indicatio

  • Ophthalmic Solution
  • Respiratory Treatment
  • World
  • Product Initiative
  • Alcon, Inc.
  • ALLERGIC CONJUNCTIVITIS - PIPELINE BY GRIFFIN DISCOVERIES BV, H1 2017
  • ZAFIRLUKAST - DRUG PROFILE

The company offers pipeline formulations for atopic dermatitis, allergic conjuntivitis, allergic asthma, and allergic rhinitis.

  • Ophthalmic Solution
  • OTC
  • Therapy
  • United States
  • Product Initiative

The pivotal Phase ## LIBERTY ASTHMA QUEST study of dupilumab for the treatment of asthma completed enrollment during the third quarter of 2016.

  • Eye Disease
  • Ophthalmic Solution
  • North America
  • United States
  • Alcon, Inc.

Marinomed also develops MAM-##. ##, an allergy compound that provides an alternative to skin allergy, allergic asthma and allergic contact dermatitis.

  • Eye Disease
  • Ophthalmic Solution
  • World
  • Product Initiative
  • Starpharma Holdings Limited